While colorectal cancers (CRC) are paradigmatic tumors invaded by effector memory lymphocytes, the mechanisms accounting for the relative resistance of MSI negative CRC to immunogenic cell death ...

Lapatinib is an antineoplastic small molecule kinase inhibitor registered by the FDA (2007) for the treatment of patients with advanced metastatic breast cancer (HER2/ERBB2+) in conjunction with the ...